Metabolic engineering and directed evolution for the production of pharmaceuticals

被引:89
作者
Chartrain, M [1 ]
Salmon, PM [1 ]
Robinson, DK [1 ]
Buckland, BC [1 ]
机构
[1] Merck & Co Inc, Merck Res Labs, Bioproc Res & Dev, Rahway, NJ 07065 USA
关键词
D O I
10.1016/S0958-1669(00)00081-1
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The tools of metabolic and enzyme engineering have been well developed in academic laboratories and are now being applied for the optimization of biocatalysts used in the production of a wide range of pharmaceutically important molecules. Engineered microorganisms with a diverse set of modified or non-native enzyme activities are being used both to generate novel products and to provide improved processes for the manufacture of established products, such as in the production of precursors, intermediates, and complete compounds of importance to the pharmaceutical industry, including polyketides, nonribosomal peptides, steroids, vitamins, and unnatural amino acids. The use of directed evolution has rapidly emerged to be the method of choice for the development and selection of mutated enzymes with improved properties. A variety of such methods have been used to alter the activity, stability and availability of an array of enzymes. The industrial practice of these technologies at large scale is, however, in its infancy and stands as an exciting challenge for process scientists today.
引用
收藏
页码:209 / 214
页数:6
相关论文
共 56 条
[21]   Primer unit specificity in rifamycin biosynthesis principally resides in the later stages of the biosynthetic pathways [J].
Hunziker, D ;
Yu, TW ;
Hutchinson, CR ;
Floss, HG ;
Khosla, C .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1998, 120 (05) :1092-1093
[22]   Spontaneous priming of a downstream module in 6-deoxyerythronolide B synthase leads to polyketide biosynthesis [J].
Jacobsen, JR ;
Cane, DE ;
Khosla, C .
BIOCHEMISTRY, 1998, 37 (14) :4928-4934
[23]   A high-throughput digital imaging screen for the discovery and directed evolution of oxygenases [J].
Joo, H ;
Arisawa, A ;
Lin, ZL ;
Arnold, FH .
CHEMISTRY & BIOLOGY, 1999, 6 (10) :699-706
[24]   Laboratory evolution of peroxide-mediated cytochrome P450 hydroxylation [J].
Joo, H ;
Lin, ZL ;
Arnold, FH .
NATURE, 1999, 399 (6737) :670-673
[25]   Tolerance and specificity of polyketide synthases [J].
Khosla, C ;
Gokhale, RS ;
Jacobsen, JR ;
Cane, DE .
ANNUAL REVIEW OF BIOCHEMISTRY, 1999, 68 :219-253
[26]   Dissecting the role of acyltransferase domains of modular polyketide synthases in the choice and stereochemical fate of extender units [J].
Lau, J ;
Fu, H ;
Cane, DE ;
Khosla, C .
BIOCHEMISTRY, 1999, 38 (05) :1643-1651
[27]   Functional expression of horseradish peroxidase in E-coli by directed evolution [J].
Lin, ZL ;
Thorsen, T ;
Arnold, FH .
BIOTECHNOLOGY PROGRESS, 1999, 15 (03) :467-471
[28]   The Streptomyces peucetius dpsY and dnrX genes govern early and late steps of daunorubicin and doxorubicin biosynthesis [J].
Lomovskaya, N ;
Doi-Katayama, Y ;
Filippini, S ;
Nastro, C ;
Fonstein, L ;
Gallo, M ;
Colombo, AL ;
Hutchinson, CR .
JOURNAL OF BACTERIOLOGY, 1998, 180 (09) :2379-2386
[29]   Doxorubicin overproduction in Streptomyces peucetius:: Cloning and characterization of the dnrU ketoreductase and dnrV genes and the doxA cytochrome P-450 hydroxylase gene [J].
Lomovskaya, N ;
Otten, SL ;
Doi-Katayama, Y ;
Fonstein, L ;
Liu, XC ;
Takatsu, T ;
Inventi-Solari, A ;
Filippini, S ;
Torti, F ;
Colombo, AL ;
Hutchinson, CR .
JOURNAL OF BACTERIOLOGY, 1999, 181 (01) :305-318
[30]   Production of the antitumor drug epirubicin (4′-epidoxorubicin) and its precursor by a genetically engineered strain of Streptomyces peucetius [J].
Madduri, K ;
Kennedy, J ;
Rivola, G ;
Inventi-Solari, A ;
Filippini, S ;
Zanuso, G ;
Colombo, AL ;
Gewain, KM ;
Occi, JL ;
MacNeil, DJ ;
Hutchinson, CR .
NATURE BIOTECHNOLOGY, 1998, 16 (01) :69-74